InterSystems is releasing global functionality for its TrakCare unified healthcare information system to screen and support patients infected with the novel coronavirus 2019-nCoV. The functionality is available to users of the latest editions of TrakCare now, and customers in China and numerous other countries, including the UK and United Arab Emirates, have already begun using it.
The functionality enables clinicians to screen patients for 2019-nCoV, using World Health Organization (WHO) guidance, and a link to the Wuhan Coronavirus Global Cases tracking app provided by the Johns Hopkins Center for Systems Science and Engineering in the USA.
Icons will indicate whether or not screening has been undertaken, and the results. There is no generally accepted treatment for 2019-nCoV. However, WHO is advising hospitals to isolate patients and protect others from infection, and the final element of the new TrakCare functionality will advise clinicians of any steps they should take.
“InterSystems keeps a close watch on the world’s healthcare requirements, so it can respond to issues that it can help to address in a timely manner,” said Dr Hazem El Oraby, CMO for TrakCare at InterSystems.
“This is a great example of how TrakCare can be updated in real-time to respond urgently to threats and deployed rapidly to the organisations and clinicians that need it; particularly those using the latest edition of our systems,” Dr El Oraby continued.
“The NHS is taking every precaution to avoid the spread of 2019-nCoV in the United Kingdom,” said Mike Fuller, marketing director, InterSystems UK. “We are proud to provide our TrakCare customers with this functionality to aid in this effort.”
